Clinical Trials in Colorado

Showing 5501-5520 of 18,143 trials

P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)

NCT04249947

An open-label, multi-center, single and cyclic ascending dose study of P-PSMA-101 autologous CAR-T cells in patients with mCRPC and SGC.

Prostatic Neoplasms, Castration-ResistantNeoplasms by Histologic TypeNeoplasms, Prostate+14 more

Poseida Therapeutics, Inc.40 participantsStarted Feb 2020

Duarte, California, United States • San Diego, California, United States • San Francisco, California, United States +7 more locations

TERMINATEDPhase 150 miles

A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer

NCT05241613

This clinical trial is evaluating a drug called AC176 in participants with metastatic castration resistant prostate cancer (mCRPC) who have progressed on at least two prior systemic therapies. The main goals of this study are to: * Identify the recommended dose of AC176 that can be given safely to participants * Evaluate the side effects of AC176 * Evaluate pharmacokinetics of AC176 * Evaluate the effectiveness of AC176

Metastatic Castration Resistant Prostate Cancer

Accutar Biotechnology Inc28 participantsStarted Mar 2022

Denver, Colorado, United States • Sarasota, Florida, United States • Detroit, Michigan, United States +2 more locations

P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)

A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer

Find Trials by Condition in Colorado

Neuroblastoma Precision Trial

IO-202 as Monotherapy and IO-202 Plus Azacitidine ± Venetoclax in Patients in AML and CMML

Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF

INFINITY™Total Ankle Replacement Follow-up

Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment.

A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm

Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis

Myeloma-Developing Regimens Using Genomics (MyDRUG)

Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia

COVID-19 Vaccine Response in Sickle Cell Disease

Evaluation of Lasofoxifene Combined With Abemaciclib in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

A Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors Including Platinum Resistant High Grade Serous Ovarian Cancer (HGSOC)

TAC T-cells for the Treatment of Claudin 18.2 Positive Solid Tumors (TACTIC-3)

Trametinib in Treating Patients With Advanced Cancer With or Without Hepatic Dysfunction

Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome

MCT for the Harvard/UCSF ROBIN Center

Radiosurgery Dose Reduction for Brain Metastases on Immunotherapy (RADREMI): A Prospective Pilot Study

Study of the Efficacy of Lurasidone in Cognitive Functioning in Bipolar Patients